Paradoxical trough effects of ‘triple therapy‘ on pulmonary function outcomes in COPD

P. A. Williamson, P. M. Short, K. L. Clearie, S. Vaidyanathan, T. C. Fardon, L. Howaniec, B. J. Lipworth (Dundee, United Kingdom)

Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Session: Pharmacological modulation of biomarkers and management
Session type: Thematic Poster Session
Number: 4581
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. A. Williamson, P. M. Short, K. L. Clearie, S. Vaidyanathan, T. C. Fardon, L. Howaniec, B. J. Lipworth (Dundee, United Kingdom). Paradoxical trough effects of ‘triple therapy‘ on pulmonary function outcomes in COPD. Eur Respir J 2010; 36: Suppl. 54, 4581

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of disease duration on pulmonary function in asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001

Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease>
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Lung function and body weight influence the outcome of pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 356s
Year: 2001

Impact of pulmonary tuberculosis on COPD outcomes
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)>
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014



Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014


The "susceptibility to exacerbation" phenotype in COPD and response to pulmonary rehabilitation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Relationship between pulmonary function and satisfaction with inhaled asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 285s
Year: 2004

Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

Effects of amlodipine on pulmonary haemodynamics in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002

Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008


Effects of a respiratory rehabilitation program over pulmonary hypertension (PH) and other right ventricular function measurements in a chronic obstructive pulmonary disease (COPD) population
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Pulmonary function changes and duration of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006